$317 Million is the total value of Tamarack Advisers, LP's 45 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 78.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HSIC | Buy | HENRY SCHEIN INCequity | $30,464,000 | +30.4% | 400,000 | +27.0% | 9.62% | +45.3% |
RIGL | Buy | RIGEL PHARMACEUTICALS INCequity | $25,410,000 | -8.5% | 7,000,000 | +9.4% | 8.02% | +2.0% |
MDT | Sell | MEDTRONIC PLCequity | $25,070,000 | -19.2% | 200,000 | -20.0% | 7.92% | -9.9% |
PCRX | Buy | PACIRA BIOSCIENCES INCequity | $21,000,000 | -3.9% | 375,000 | +4.2% | 6.63% | +7.2% |
PDCO | Buy | PATTERSON COS INCequity | $14,919,000 | +3.4% | 495,000 | +4.2% | 4.71% | +15.2% |
TPB | Sell | TURNING POINT BRANDS INCequity | $13,131,000 | -28.3% | 275,000 | -31.2% | 4.15% | -20.1% |
ELY | Buy | CALLAWAY GOLF COMPANYequity | $12,434,000 | +123.4% | 450,000 | +172.7% | 3.93% | +149.1% |
UTHR | Buy | UNITED THERAPEUTICS CORPequity | $11,998,000 | +7.9% | 65,000 | +4.8% | 3.79% | +20.2% |
PRGO | Buy | PERRIGO CO PLCequity | $11,833,000 | +416.0% | 250,000 | +400.0% | 3.74% | +474.8% |
VRAY | Sell | VIEWRAY INCequity | $11,536,000 | -12.6% | 1,600,000 | -20.0% | 3.64% | -2.6% |
ITGR | Sell | INTEGER HOLDINGS CORPequity | $11,168,000 | -12.2% | 125,000 | -7.4% | 3.53% | -2.1% |
MSON | Buy | MISONIX INCequity | $10,120,000 | +21.7% | 400,000 | +6.7% | 3.20% | +35.6% |
LNTH | Sell | LANTHEUS HOLDINGS INCequity | $10,015,000 | -19.5% | 390,000 | -13.3% | 3.16% | -10.2% |
ANGO | Buy | ANGIODYNAMICS INCequity | $9,079,000 | +11.5% | 350,000 | +16.7% | 2.87% | +24.4% |
STRM | STREAMLINE HEALTH SOLUTIONSequity | $8,629,000 | -1.1% | 4,930,882 | 0.0% | 2.72% | +10.2% | |
SIBN | Buy | SI-BONE INCequity | $8,568,000 | +6.8% | 400,000 | +56.9% | 2.70% | +19.0% |
ICUI | Buy | ICU MEDICAL INCequity | $8,168,000 | +16.7% | 35,000 | +2.9% | 2.58% | +30.1% |
ATRC | Sell | ATRICURE INCequity | $8,137,000 | -31.6% | 117,000 | -22.0% | 2.57% | -23.8% |
MDRX | Buy | ALLSCRIPTS HEALTHCARE SOLUTIequity | $7,688,000 | -7.7% | 575,000 | +27.8% | 2.43% | +2.9% |
STE | New | STERIS PLCequity | $7,354,000 | – | 36,000 | +100.0% | 2.32% | – |
BVS | Buy | BIOVENTUS INC - Aequity | $6,797,000 | -18.7% | 480,000 | +1.1% | 2.15% | -9.4% |
RDNT | Sell | RADNET INCequity | $5,569,000 | -26.5% | 190,000 | -15.6% | 1.76% | -18.1% |
THC | New | TENET HEALTHCARE CORPequity | $4,983,000 | – | 75,000 | +100.0% | 1.57% | – |
PHR | Sell | PHREESIA INCequity | $4,628,000 | -32.5% | 75,000 | -32.9% | 1.46% | -24.7% |
AHCO | Sell | ADAPTHEALTH CORPequity | $4,076,000 | -50.4% | 175,000 | -41.7% | 1.29% | -44.7% |
ISEE | Sell | IVERIC BIO INCequity | $4,060,000 | +60.9% | 250,000 | -37.5% | 1.28% | +79.3% |
PLXS | Buy | PLEXUS CORPequity | $3,576,000 | +179.4% | 40,000 | +185.7% | 1.13% | +211.0% |
TALK | New | TALKSPACE INCequity | $2,920,000 | – | 800,000 | +100.0% | 0.92% | – |
Sell | DERMTECH INCequity | $2,729,000 | -51.4% | 85,000 | -37.0% | 0.86% | -45.8% | |
SPY | New | SPY US 10/01/21 P440put | $2,060,000 | – | 2,000 | +100.0% | 0.65% | – |
NVST | New | ENVISTA HOLDINGS CORPequity | $1,881,000 | – | 45,000 | +100.0% | 0.59% | – |
New | SOMALOGIC INCequity | $1,859,000 | – | 150,000 | +100.0% | 0.59% | – | |
New | TERRASCEND CORPequity | $1,760,000 | – | 250,000 | +100.0% | 0.56% | – | |
ARKG | New | ARKG US 10/15/21 P85put | $735,000 | – | 750 | +100.0% | 0.23% | – |
CERS | CERUS CORPequity | $457,000 | +3.2% | 75,000 | 0.0% | 0.14% | +15.2% | |
HOLX | New | HOLX US 12/17/21 C75call | $420,000 | – | 1,000 | +100.0% | 0.13% | – |
HSIC | New | HSIC US 11/19/21 C80call | $405,000 | – | 1,500 | +100.0% | 0.13% | – |
GTBIF | New | GREEN THUMB INDUSTRIES INCequity | $278,000 | – | 10,000 | +100.0% | 0.09% | – |
VTRS | New | VTRS US 01/21/22 C15call | $250,000 | – | 5,000 | +100.0% | 0.08% | – |
PFE | New | PFE US 11/19/21 C43call | $156,000 | – | 1,000 | +100.0% | 0.05% | – |
NUVA | New | NUVA US 11/19/21 P65put | $143,000 | – | 231 | +100.0% | 0.04% | – |
RIGL | New | RIGL US 01/21/22 C10call | $100,000 | – | 5,000 | +100.0% | 0.03% | – |
New | Somalogic Inc Warrantwarrant | $69,000 | – | 20,000 | +100.0% | 0.02% | – | |
MSACW | MEDICUS SCIENCES ACQ -CW27warrant | $47,000 | -29.9% | 66,665 | 0.0% | 0.02% | -21.1% | |
BMRN | New | BMRN US 10/15/21 C85call | $23,000 | – | 1,500 | +100.0% | 0.01% | – |
Exit | XLV US 07/16/21 P120put | $0 | – | -1,500 | -100.0% | -0.01% | – | |
Exit | GLD US 09/17/21 C200call | $0 | – | -5,000 | -100.0% | -0.02% | – | |
Exit | PFE US 07/16/21 C40call | $0 | – | -3,500 | -100.0% | -0.02% | – | |
Exit | CTVA US 07/16/21 C44call | $0 | – | -1,500 | -100.0% | -0.04% | – | |
Exit | ARKG US 07/16/21 P90put | $0 | – | -1,500 | -100.0% | -0.06% | – | |
Exit | BMY US 09/17/21 C70call | $0 | – | -2,500 | -100.0% | -0.07% | – | |
Exit | BSX US 07/16/21 C42call | $0 | – | -2,000 | -100.0% | -0.07% | – | |
LH | Exit | LABORATORY CRP OF AMER HLDGSequity | $0 | – | -1,000 | -100.0% | -0.08% | – |
Exit | SPY US 07/16/21 P420put | $0 | – | -3,500 | -100.0% | -0.09% | – | |
Exit | HOLX US 12/17/21 C75call | $0 | – | -2,500 | -100.0% | -0.16% | – | |
BIO | Exit | BIO-RAD LABORATORIES-Aequity | $0 | – | -1,000 | -100.0% | -0.18% | – |
Exit | ABT US 08/20/21 P120put | $0 | – | -1,000 | -100.0% | -0.19% | – | |
CMIIU | Exit | CM LIFE SCIENCES II INCequity unit | $0 | – | -50,000 | -100.0% | -0.19% | – |
AYRWF | Exit | AYR WELLNESS INCequity | $0 | – | -31,500 | -100.0% | -0.25% | – |
Exit | IWM US 08/20/21 P220put | $0 | – | -5,000 | -100.0% | -0.45% | – | |
DGX | Exit | QUEST DIAGNOSTICS INCequity | $0 | – | -15,000 | -100.0% | -0.56% | – |
CNC | Exit | CENTENE CORPequity | $0 | – | -35,000 | -100.0% | -0.72% | – |
MSACU | Exit | MEDICUS SCIENCES ACQUISITI-Aequity | $0 | – | -296,636 | -100.0% | -0.81% | – |
INNV | Exit | INNOVAGE HOLDING CORPequity | $0 | – | -141,000 | -100.0% | -0.85% | – |
CI | Exit | CIGNA CORPequity | $0 | – | -35,000 | -100.0% | -2.35% | – |
CVS | Exit | CVS HEALTH CORPequity | $0 | – | -100,000 | -100.0% | -2.36% | – |
VTRS | Exit | VIATRIS INCequity | $0 | – | -825,000 | -100.0% | -3.34% | – |
UNH | Exit | UNITEDHEALTH GROUP INCequity | $0 | – | -30,000 | -100.0% | -3.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERADIGM ORD | 32 | Q3 2023 | 13.9% |
STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
ATRICURE ORD | 29 | Q3 2023 | 7.6% |
PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
HOLOGIC INC | 17 | Q1 2022 | 6.5% |
SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
Correvio Pharma Corp. | February 15, 2019 | ? | ? |
Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-11-16 |
13F-HR | 2023-08-10 |
SC 13D/A | 2023-06-22 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-13 |
SC 13D/A | 2022-12-01 |
13F-HR | 2022-11-15 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.